Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adult, Advairmay, andArzerra, andBactroban, andCoreg, andDuac, andEno, andEpivir, andLovaza, andRequip, andRibena, andSelzentry, animal, antitrust, API, asymptomatic, bilateral, bipolar, BothHycamtin, category, CCM, certainty, compliant, content, CPI, Daiichi, deliberately, discretion, discretionary, doctor, EMAP, embed, equating, ExcludingCervarix, fromAugmentin, geography, GMP, HPV, imperative, inAquafresh, inAvodart, incident, includingAbreva, includingPanadol, incomplete, inJalyn, innate, intensify, JV, lawfully, lersivirine, lifecycle, Lip, misaligned, misuse, multinational, noncompliance, ofAdvair, ofAvodart, ofBenlysta, ofBonviva, ofCervarix, ofDermovate, ofLamictal, ofLucozade, ofPromacta, ofToctino, onFebruary, pursuit, reappointment, ReportedBenlysta, retrieval, RPI, Sankyo, sarcoma, signal, Skin, spirit, stake, storage, storm, StrongBactroban, strongCervarix, suboptimal, substitution, surveillance, susceptible, tenure, theAdvair, TheAvodart, theBenlysta, theLamictal, TheMaxinutrition, Theravance, TheSensodyne, theVesicare, toArixtra, toCombivir, toLamictal, toSeretide, unacceptable, unresolved, weakening, welfare, XR
Removed:
create, Crispin, delegate, diversified, exemption, Mellon
Filing tables
Filing exhibits
GSK similar filings
Filing view
External links